European Archives - Page 782 of 1345 - European Medical Journal

EMJ Microbiology 2.1 2021 Feature Image

Cutaneous Mucormycosis of the Interscapular Region in an Immunocompetent Patient

Mucormycosis is an uncommon but emerging opportunistic fungal infection with high morbidity and mortality…

EMJ Microbiology 2.1 2021 Feature Image

Direct Linkage Between the Prevalence of Known Common Extra-intestinal Pathogenic Escherichia coli Sequence Types in UK Sewage to Those Causing E. coli Urinary Tract Infections and Sepsis

Escherichia coli are a hugely diverse group of bacteria that include harmless commensals as well as virulent pathogens…

EMJ Microbiology 2.1 2021 Feature Image

Aspergillus Sensitisation in Patients with Severe Asthma

Asthma is a chronic inflammatory disease of the respiratory tract and a serious global medical and social problem.1 It is known that…

EMJ Microbiology 2.1 2021 Feature Image

Do Infections Start in the Gut? Patients with Inflammatory Bowel Disease Have a Higher Risk of Periprosthetic Joint Infection after Surgery

A large body of evidence is emerging to implicate that dysregulation of the gut microbiome (dysbiosis) increases the risk of surgical…

EMJ Microbiology 2.1 2021 Feature Image

Plasma-Activated Water as a New Weapon Against Multidrug-Resistant Bacteria

Multidrug-resistant (MDR) bacteria, or ‘superbugs’, pose an impending threat for human health around the world. Common infections are…

The reality of caregiving in a crisis

While the pandemic has placed pressure and strain on all members of society, it has had a profound and lesser acknowledged effect on unpaid and family carers. What has been the impact of COVID-19 on those looking after loved ones and how can we better support them in the future?

Dr Jerome Kim on vaccines

Dr Jerome Kim, Director General, International Vaccine Institute, discusses pharma’s role in addressing vaccine hesitancy and refusal.

EMJ Podcast: How to Ignite Innovation

This week, Jonathan and Professor Wendy Tindale delve into the world of innovation, considering what ‘value’ means, the benefits and burdens of working within the NHS, and discuss the national differences within innovation.

EMJ Oncology 9 [Supplement 5] 2021

In this supplement to EMJ Oncology, two internationally renowned experts, Andres J. Muñoz Martin and Annie Young, explored risk assessment…

Trial Outcomes and Sub-Analyses of Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Interviews with Key Opinion Leaders

EMJ conducted interviews with two key opinion leaders and specialists in the prevention and treatment of cancer-related venous…